Zhengye Biotechnology Holding Ltd Income Statement

Income Statement Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 38.76M29.95M25.94M
Cost of Revenue 16.74M13.32M13.23M
Gross Profit 22.02M16.63M12.71M
Operating items
Research & Development 2.00M1.68M1.78M
Selling, General & Administrative 3.62M3.34M3.09M
Other Operating Expenses 6.60M5.24M5.54M
Operating Expenses 12.22M10.26M10.42M
Operating Income 9.81M6.37M2.29M
EBIT 9.81M6.37M2.29M
Non-operating items
Interest & Investment Income 0.02M0.04M0.03M
Other Non Operating Income 0.10M0.06M0.10M
Non Operating Income -0.29M-0.17M-0.28M
Net income details
EBT 9.52M6.19M2.00M
Tax Provisions 1.41M0.88M0.13M
Profit After Tax 8.30M5.31M1.85M
Equity Income 6.96M4.45M1.55M
Income from Non-Controlling Interests 1.34M0.86M0.30M
Income from Continuing Operations 8.11M5.31M1.87M
Consolidated Net Income 8.11M5.31M1.87M
Income towards Parent Company 8.11M5.31M1.87M
Net Income towards Common Stockholders 8.11M5.31M1.87M
Additional items
EPS (Basic) 0.150.100.03
EPS (Weighted Average and Diluted) 0.150.100.03
Shares Outstanding (Weighted Average) 47.17M47.17M
Shares Outstanding (Diluted Average) 6.80M6.46M6.36M
EBITDA 8.30M5.31M1.88M
Interest Expenses 0.42M0.63M0.55M
Tax Rate 14.84%14.29%6.42%